BioCryst Pharmaceuticals, Inc. (BCRX)
6.665
0.00 (0.00%)
USD |
NASDAQ |
Jan 20, 16:00
6.65
-0.02
(-0.23%)
After-Hours: 19:05
BioCryst Pharmaceuticals Total Assets (Quarterly): 446.42M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Astria Therapeutics, Inc. | 271.87M |
| Hologic, Inc. | 9.015B |
| Bruker Corp. | 6.435B |
| Viatris, Inc. | 37.92B |
| KalVista Pharmaceuticals, Inc. | 339.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 834.31M |
| Shareholders Equity (Quarterly) | -387.89M |
| Debt to Equity Ratio | -1.761 |
| Current Ratio | 1.870 |
| Net Debt Paydown Yield | 2.10% |